MedPath

Biopharma Plasma LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 3:2
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Phase 3
2 (66.7%)
Phase 4
1 (33.3%)

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Phase 3
Recruiting
Conditions
Primary Immune Thrombocytopenia
Interventions
Drug: Intravenous immunoglobulin (IVIG), 10% solution for infusion
First Posted Date
2022-06-16
Last Posted Date
2022-11-16
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
36
Registration Number
NCT05422365
Locations
πŸ‡ΊπŸ‡¦

Municipal non-profit enterprise "City Clinical Hospital No. 4" of the Dnipro City Council, Dnipro, Ukraine

πŸ‡ΊπŸ‡¦

Municipal non-profit enterprise "Khmelnytskyi Regional Hospital" of the Khmelnytskyi Regional Council, Khmelnytskyi, Ukraine

πŸ‡ΊπŸ‡¦

Municipal Non-Profit Enterprise "Kirovohrad Regional Hospital of the Kirovohrad Regional Council", Kropyvnytskyi, Ukraine

and more 9 locations

Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women

Phase 4
Recruiting
Conditions
Pregnancy Related
Interventions
Drug: Human Anti-D (rh) immunoglobulin
First Posted Date
2022-02-18
Last Posted Date
2024-04-18
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
281
Registration Number
NCT05245734
Locations
πŸ‡ΊπŸ‡¦

Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council", Cherkasy, Cherkasy Region, Ukraine

πŸ‡ΊπŸ‡¦

Municipal non-profit enterprise "Maternity hospital" of the Chernihiv city council, Chernihiv, Ukraine

πŸ‡ΊπŸ‡¦

Municipal non-profit enterprise "Chernivtsi Regional Perinatal Center", Chernivtsi, Ukraine

and more 13 locations

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Phase 3
Completed
Conditions
Pneumonia
Covid19
Interventions
First Posted Date
2020-08-05
Last Posted Date
2020-10-14
Lead Sponsor
Biopharma Plasma LLC
Target Recruit Count
76
Registration Number
NCT04500067
Locations
πŸ‡ΊπŸ‡¦

Site 08 - "Central City Clinical Hospital of Ivano-Frankivsk City Council", Ivano-Frankivs'k, Ivano-Frankivs'k Region, Ukraine

πŸ‡ΊπŸ‡¦

Site 02 - "Bila Tserkva City Hospital β„–3", Bila Tserkva, Kyiv Region, Ukraine

πŸ‡ΊπŸ‡¦

Site 03 - "Lviv Regional Infectious Diseases Clinical Hospital", Lviv, Lviv Region, Ukraine

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.